(Q48660009)

English

Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure.

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. (English)

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

0 references

hospitalization

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

author name string

Junnichi Ishii

1

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

Masanori Nomura

2

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

Yuu Nakamura

3

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

Hiroyuki Naruse

4

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

Yoshihisa Mori

5

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

Takashi Ishikawa

6

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

Toshikazu Ando

7

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

Hiroshi Kurokawa

8

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

Takeshi Kondo

9

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

Youichi Nagamura

10

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

Kouji Ezaki

11

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

Hitoshi Hishida

12

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

American Journal of Cardiology

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

89

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

6

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

691-695

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

Circulating cardiac troponin I in severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902341-4

7 January 2021

Comparison of peak exercise oxygen uptake in men versus women in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902341-4

7 January 2021

A novel biochemical approach to congestive heart failure: cardiac troponin T

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902341-4

7 January 2021

Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902341-4

7 January 2021

Cardiac troponin I as diagnostic and prognostic marker in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902341-4

7 January 2021

Cardiac troponins in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902341-4

7 January 2021

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902341-4

7 January 2021

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902341-4

7 January 2021

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902341-4

7 January 2021

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902341-4

7 January 2021

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902341-4

7 January 2021

Identifiers

10.1016/S0002-9149(01)02341-4

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/11897211

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48660009&oldid=2067405508"